MEDIPHARM LABS CORP by Medipharm Labs Corporation (MEDIF) Stock Price, Quote, News & History

SPY765.22−0.05%QQQ736.16−0.05%BTC/USD83,495.00−1.12%DIA514.12+0.02%GLD377.54−0.10%TLT78.69+0.09%

MEDIPHARM LABS CORP by Medipharm Labs Corporation (MEDIF) Stock Price, Quote, News & History

MEDIFOTCQB

Trade with Public

$0.0510

0.00040.79%

At close: Sep 28, 5:00 PM EST

$0.0524

0.001452.84%

After Hours: Apr 28, 8:00 AM EST

OverviewNews Earnings Forecast Financials Sentiment Compare

Key Statistics

Open

$0.05

Volume / Avg.

31.25K / 59.29K

Day Range

$0.05 - $0.05

52 Wk Range

0.04 - 0.08

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

Recent Medipharm Labs Corp News

This Week In Cannabis: America's Crackdown Down On Hemp, Global Reform, Industry Gathering In Chicago

Congress advances hemp THC ban as cannabis leaders prep for Benzinga's Chicago conference. Global markets shift. Here's the full recap.

Javier Hasse

This Week In Cannabis: Trump Policy Updates, Corporate Moves, Regulatory Shifts And Product Innovations

This week in cannabis: major mergers, innovative launches, key regulatory updates & leadership changes drive industry transformation.

Javier Hasse

CBD Pharma Co. MediPharm: 37% Increase In Q3 International Sales, 15% YoY Revenue Growth

CBD-based pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Thursday its third quarter financial results for the three months ended Sept. 30, 2024."Q3 2024 was a major step in the right direction towards profitability," Greg Hunter, the company's CFO, said. "Paying off our debt and rationalizing facilities, pursuing cost efficiencies while growing our higher margin international revenues are all critical elements to position us for long-term sustainable growth."

Jelena Martinovic

MediPharm Q2 Loss Narrows, Adjusted EBITDA Climbs As Gross Profit Improves Nearly 300% YoY

Cannabinoids-focused pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Wednesday financial results for the second quarter ended June 30, 2024, revealing an 8% year-over-year and 6% sequential increase to CA$10.3 million ($7.5 million). "We are very pleased with our Q2 results, showcasing substantial improvements in both revenue and profitability," David Pidduck, the company's CEO, said. "The strategic initiatives implemented, including cost reductions and operational efficiencies, are yielding positive results. We are particularly encouraged by the continued growth in our international sales and the progress in innovation of non-combustible cannabis formats."

Jelena Martinovic

This Cannabis Co With Significant Growth Potential And Other Hot Weed Stocks Soon To Report Earnings, What Investors Need To Know Now

Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF), a cannabis operator with vertical operations in Arizona and Ohio, said it will release its financial results for the second quarter ended June 30, 2024, before the market opens on Tuesday, Aug. 20, 2024. A conference call and webcast will take place on the same day at 08:00 am Eastern Time. Auxly Cannabis Group Inc. (TSX: XLY) (OTCQB: CBWTF) will report earnings results for its second quarter ended June 30, 2024, on Thursday, Aug. 15, 2024, before the financial markets open.Cannabinoids-focused MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) will release its second quarter financial results for the period ended June 30, 2024, before markets open on Wednesday, Aug. 14, 2024. A conference call and audio webcast will take place the same day at 8:30 am Eastern Time.

Jelena Martinovic

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-981.00K

Investing Cash Flow (TTM)

412.00K

Financing Cash Flow (TTM)

47.00K

Free Cash Flow (TTM)

-1.04M

Capital Expenditure (TTM)

-63.00K

Net Change in Cash (TTM)

-522.00K

Valuation Metrics

Enterprise Value

$14.47M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

0.74

PB Ratio (TTM)

0.86

Earnings Yield % (TTM)

-13.97%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$0.06

Company Debt

Total Debt

$411.00K

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

-$85.00K

Total Cash

$9.85M

Debt to Equity

0.01

Issuance of Debt (TTM)

$415.00K

Repayment of Debt (TTM)

-$581.00K

Key Statistics

Open

$0.05

Volume / Avg.

31.25K / 59.29K

Day Range

$0.05 - $0.05

52 Wk Range

0.04 - 0.08

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

About

Sector

Health Care

Industry

Pharmaceuticals

MediPharm Labs Corp and its subsidiaries produce cannabis, purified and pharmaceutical-like cannabis extracts, related derivative products, and cannabis-related medical information and services. Its operating subsidiaries hold cultivation, standard p...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

FAQ

How do I buy MEDIPHARM LABS CORP by Medipharm Labs Corporation (MEDIF) stock?

You can purchase shares of MEDIPHARM LABS CORP by Medipharm Labs Corporation (OTCQB:MEDIF) through any online brokerage.

View our list of the best stock brokerages

Who are MEDIPHARM LABS CORP by Medipharm Labs Corporation (MEDIF) competitors?

There are no as such competitors for MEDIPHARM LABS CORP by Medipharm Labs Corporation.

What is the forecast, or price target, for MEDIPHARM LABS CORP by Medipharm Labs Corporation (MEDIF) stock?

There is no analysis for MEDIPHARM LABS CORP by Medipharm Labs Corporation to provide a consensus price target.

What is the current price for MEDIPHARM LABS CORP by Medipharm Labs Corporation (MEDIF)?

The stock price for MEDIPHARM LABS CORP by Medipharm Labs Corporation (OTCQB: MEDIF) is $0.051 last updated September 28, 2026 at 1:20 PM EDT.

Does MEDIPHARM LABS CORP by Medipharm Labs Corporation (MEDIF) pay a dividend?

There are no upcoming dividends for MEDIPHARM LABS CORP by Medipharm Labs Corporation.

When is MEDIPHARM LABS CORP by Medipharm Labs Corporation (OTCQB:MEDIF) reporting earnings?

MEDIPHARM LABS CORP by Medipharm Labs Corporation does not have any upcoming earnings scheduled.

Is MEDIPHARM LABS CORP by Medipharm Labs Corporation (MEDIF) going to split?

There is no upcoming split for MEDIPHARM LABS CORP by Medipharm Labs Corporation.

What sector and industry does MEDIPHARM LABS CORP by Medipharm Labs Corporation (MEDIF) operate in?

MEDIPHARM LABS CORP by Medipharm Labs Corporation is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCQB.